Today: September 30, 2024
Today: September 30, 2024

Latest From Reuters

Business|Economy|Health

Sanofi eyes German insulin investment of up to $1.6 billion, source says

French drugmaker Sanofi is nearing a decision to invest between 1.3 billion and 1.5 billion euros ($1.4-$1.6 billion) to upgrade its production of long-acting insulin shots in

Sanofi eyes German insulin investment of up to $1.6 billion, source says
Health

AstraZeneca's COVID prevention drug application gets EU fast-track assessment

AstraZeneca said on Monday that the European Union drug regulator has accepted a market authorisation application for its investigational COVID-19 prevention drug, sipavibart, for an

AstraZeneca's COVID prevention drug application gets EU fast-track assessment
Business|Health

Boots chief quits after Walgreens' sale plan stalls

The boss of British health and beauty retailer Boots is quitting after U.S. owner Walgreens Boots Alliance's plans for a sale or stock market listing of the chain stalled, according to a

Boots chief quits after Walgreens' sale plan stalls
Health

US FDA approves Roche's drug for a chronic blood disorder

The U.S.

US FDA approves Roche's drug for a chronic blood disorder
Health

Teva launches generic version of Novo Nordisk's diabetes drug Victoza

Teva Pharmaceuticals said on Monday it had launched a generic version of Novo Nordisk's Victoza to treat patients with type 2 diabetes, making it the first generic GLP-1 drug in the United

Teva launches generic version of Novo Nordisk's diabetes drug Victoza
Health

EU regulator backs approval for ARS Pharma's nasal spray alternative to EpiPen

ARS Pharmaceuticals said on Friday the European Medicines Agency (EMA) has recommended the approval of its needle-free emergency treatment, EURneffy, for allergic

EU regulator backs approval for ARS Pharma's nasal spray alternative to EpiPen
Business|Health

Amylyx to buy bankrupt Eiger's experimental drug to treat low blood sugar

Amylyx Pharmaceuticals has agreed to buy the rights to bankrupt drugmaker Eiger BioPharmaceuticals' experimental drug for low blood sugar in a $35.1 million deal, Eiger said in a filing on

Amylyx to buy bankrupt Eiger's experimental drug to treat low blood sugar
Business|Health

Lilly files more lawsuits to curb sales of counterfeit Mounjaro

U.S. drugmaker Eli Lilly said on Thursday it was suing six more entities including medical spas and wellness centers for selling products claiming to contain tirzepatide, the active

Lilly files more lawsuits to curb sales of counterfeit Mounjaro
Health

US FDA puts Zentalis' cancer drug studies on partial hold after patient deaths

The U.S. health regulator has placed three studies of Zentalis Pharmaceuticals' cancer drug on partial clinical hold following the death of two trial participants, the company said on

US FDA puts Zentalis' cancer drug studies on partial hold after patient deaths
Health

German vaccine panel endorses Astra-Sanofi's RSV shot for infants

Germany's influential vaccine advisory panel said on Thursday all infants in the country should receive AstraZeneca and Sanofi's antibody therapy to protect them against the

German vaccine panel endorses Astra-Sanofi's RSV shot for infants
Business|Health

Sanofi-backed Formation Bio raises $372 million in late-stage funding round

AI-based drug developer Formation Bio said on Wednesday that it has raised $372 million in a late-stage funding round, with a significant participation from French drugmaker Sanofi.

Sanofi-backed Formation Bio raises $372 million in late-stage funding round
Business|Economy|Health

Teva settles tax dispute in Israel with $750 million payment

Teva Pharmaceutical Industries has entered into a deal with the Israel Tax Authority to resolve all pending litigation related to taxes payable for the years from 2008 to 2020, the

Teva settles tax dispute in Israel with $750 million payment
Health

Nestle launches website for individuals on weight loss drugs

Nestle's health unit on Tuesday launched a web platform to provide nutritional support for individuals on weight loss programs, including those using GLP-1 medications.

Nestle launches website for individuals on weight loss drugs
Environment|Health

Italy must not ignore Ilva steel plant health risks, EU court rules

A steel plant in the southern Italian city of Taranto should be shut down if it poses significant threats to the environment and human health, the European Court of Justice said

Italy must not ignore Ilva steel plant health risks, EU court rules
Business|Health

Therapy developer Alumis seeks up to $1 billion valuation in US IPO

Alumis is targeting a valuation of up to $1.01 billion in its initial public offering in the United States, the therapy developer said on Monday.

Therapy developer Alumis seeks up to $1 billion valuation in US IPO
Health

Doctors must keep Ozempic prescriptions in check, Danish regulator says

Doctors in Denmark should limit how many packs of Novo Nordisk's Ozempic diabetes drug patients can pick up at one time, the Danish Patient Safety Authority said on Monday, amid

Doctors must keep Ozempic prescriptions in check, Danish regulator says
Business|Health

Takeda gives Sun Pharma, Cipla rights to commercialize gastro drug in India

Japan's Takeda Pharmaceutical gave India's Sun Pharmaceutical and Cipla the rights to commercialize gastrointestinal drug Vonoprazan in the country.

Takeda gives Sun Pharma, Cipla rights to commercialize gastro drug in India
Economy|Environment|Health

US lawmakers seek crackdown on Chinese used cooking oil imports over fraud concerns

A group of U.S. farm state senators is pushing for a regulatory crackdown on surging imports of used cooking oil from China and elsewhere amid concerns some of the shipments could be

US lawmakers seek crackdown on Chinese used cooking oil imports over fraud concerns
Business|Economy|Health

Illumina to take $1.47 billion goodwill impairment charge related to Grail in Q2

Illumina said on Thursday it will take a goodwill impairment charge of $1.47 billion in the second quarter related to recently spun-off cancer diagnostic test maker Grail.

Illumina to take $1.47 billion goodwill impairment charge related to Grail in Q2
Business|Health

Altria seeks FDA marketing order for oral nicotine pouch products

Tobacco giant Altria said on Wednesday it had submitted Premarket Tobacco Product Applications (PMTAs) to the U.S. Food and Drug Administration for its on!

Altria seeks FDA marketing order for oral nicotine pouch products
Business|Economy|Health

Novo Nordisk ends kidney disease trial, books $816 million impairment in Q2

Novo Nordisk said on Wednesday it would recognise an impairment loss of about 5.7 billion Danish crowns ($816.72 million) in the second quarter of 2024, after its CLARION-CKD

Novo Nordisk ends kidney disease trial, books $816 million impairment in Q2
Health

US CDC alerts healthcare providers of increase in dengue cases

The U.S. Centers for Disease Control and Prevention issued an advisory on Tuesday alerting healthcare providers about an increased risk of dengue virus infections in the United States.

US CDC alerts healthcare providers of increase in dengue cases
Health

Peru to stop labeling transgender people as mentally ill

Peru will stop listing individuals who identify as transgender, among others, as suffering from mental disorders, the country's health ministry announced on Tuesday, following a

Peru to stop labeling transgender people as mentally ill
Health

Nearly 40% of Italian teens take drugs, government report finds

Almost 960,000 Italians aged between 15 and 19, or 39% of them, have consumed illegal substances at least once, an annual government report to parliament showed on Tuesday, as drug

Nearly 40% of Italian teens take drugs, government report finds
Health

At least 2,000 medical evacuations from Gaza prevented by Rafah crossing closure, says WHO

The closure of the Rafah crossing between Egypt and Gaza has prevented the medical evacuations of at least 2,000 patients, a World Health Organization official said on Tuesday,

At least 2,000 medical evacuations from Gaza prevented by Rafah crossing closure, says WHO

Follow